Central administration of a cytochrome P450-7 alpha product 7 alpha-hydroxypregnenolone improves spatial memory retention in cognitively impaired aged rats by Yau, Joyce L. W. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Central administration of a cytochrome P450-7 alpha product 7
alpha-hydroxypregnenolone improves spatial memory retention
in cognitively impaired aged rats
Citation for published version:
Yau, JLW, Noble, J, Graham, M & Seckl, JR 2006, 'Central administration of a cytochrome P450-7 alpha
product 7 alpha-hydroxypregnenolone improves spatial memory retention in cognitively impaired aged rats'
Journal of Neuroscience, vol. 26, no. 43, pp. 11034-11040. DOI: 10.1523/JNEUROSCI.3189-06-2006
Digital Object Identifier (DOI):
10.1523/JNEUROSCI.3189-06-2006
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Neuroscience
Publisher Rights Statement:
Copyright © 2006 Society for Neuroscience
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Behavioral/Systems/Cognitive
Central Administration of a Cytochrome P450-7B Product
7-Hydroxypregnenolone Improves Spatial Memory
Retention in Cognitively Impaired Aged Rats
Joyce L. W. Yau, June Noble, Mags Graham, and Jonathan R. Seckl
Endocrinology Unit, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom
Pregnenolone (PREG) and dehydroepiandrosterone (DHEA) have been reported to improve memory in aged rodents. In brain, these
neurosteroids are transformed predominantly into 7-hydroxylated metabolites by the cytochrome P450-7B1 (CYP7B). The biological
role of steroid B-ring hydroxylation is unclear. It has been proposed to generate bioactive derivatives that enhance cognition, immune,
and other physiological processes. In support, 7-hydroxylatedDHEA increases the immune response inmicewith greater potency than
the parent steroid. Whether the memory-enhancing effects of PREG in rats is mediated via its 7-hydroxylated metabolite 7-
hydroxyPREG is not known. We investigated this by treating memory-impaired aged rats (identified by their spatial memory perfor-
mances in the Morris water maze task compared with young controls) with 7-hydroxyPREG or PREG administered intracerebroven-
tricularly using osmoticminipumps and then tested the rats duringweek 2 of steroid treatment in the eight-armradial-armversion of the
water maze (RAWM) that allows repeated assessment of learning. CYP7B bioactivity in hippocampal tissue (percentage conversion of
[14C]DHEA to [14C]7-hydroxyDHEA) was decreased selectively in memory-impaired aged rats compared with both young and
memory-intact aged rats. 7-hydroxyPREG (100 ng/h) but not PREG (100 ng/h) administration to memory-impaired aged rats for 11 d
enhanced spatial memory retention (after a 30 min delay between an exposure trial 1 and test trial 2) in the RAWM. These data provide
evidence for a biologically active enzyme product 7-hydroxyPREG and suggests that reduced CYP7B function in the hippocampus of
memory-impaired aged rats may, in part, be overcome by administration of 7-hydroxyPREG.
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Introduction
In addition to being a prime target site of peripheral steroid hor-
mones, the brain itself can also synthesize steroids de novo from
cholesterol or by in situ metabolism of blood-borne precursors
(Robel and Baulieu, 1995; Vallee et al., 2004). Blood levels of
dehydroepiandrosterone (DHEA) in humans decline signifi-
cantly with age and parallels cognitive decline (Orentreich et al.,
1992). Rodents, in contrast, have very little DHEA in brain be-
cause of the lack (or undetectable levels) of cyp17 (17-
hydroxylase) that catalyzes the conversion of pregnenolone
(PREG) toDHEA in rat andmouse adrenal cortex (LeGoascogne
et al., 1991; Mellon and Deschepper, 1993). However, high levels
of PREG, the neurosteroid precursor ofDHEA, can be detected in
the hippocampus of young rats, whereas aged rats have lower
levels, which correlate with cognitive deficits (Vallee et al., 1997).
PREG administration improves learning andmemory in rats and
mice (Flood et al., 1992, 1995; Vallee et al., 1997), but the mech-
anisms involved are unclear.
Localmetabolismmay influence steroid activity by converting
precursor steroid to active or inactive metabolites (Mellon and
Deschepper, 1993; Seckl, 1997). We have previously character-
ized a novel cytochrome P450-7B1 (CYP7B), from a rat hip-
pocampal cDNA library (Stapleton et al., 1995). CYP7B, unusu-
ally for a cytochrome P450, is highly expressed in brain,
particularly in the hippocampus (Rose et al., 1997). DHEA and
PREG are converted to their respective 7-hydroxylated metab-
olites by recombinant CYP7B in vitro (Rose et al., 1997). The
main product of DHEA or PREG incubation with rat brain ex-
tracts is also 7-hydroxyDHEA or 7-hydroxyPREG (Akwa et
al., 1992), suggesting that the major metabolic route for these
neurosteroids in brain is 7-hydroxylation by CYP7B metabo-
lism. Extrahepatic tissues from homozygous Cyp7b/mice (in-
cluding brain) fail to metabolize DHEA and PREG to their major
7 (and 7) products (Rose et al., 2001). Thus, outside the liver,
CYP7B provides the primary metabolic route for DHEA, PREG,
and related 3-hydroxysteroids. The role played by the 7-
hydroxy metabolites in brain is not clear. Intriguingly, CYP7B
may convert precursor steroids to active products. Thus, 7-
hydroxyDHEA, but not DHEA, is neuroprotective in hippocam-
pal cultures, reducing ischemia-induced neuronal damage in
vitro (Pringle et al., 2003). Similarly, 7-hydroxyDHEA, but not
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DHEA, acts as an immune stimulant in vitro (Lafaye et al., 1999).
Given that PREG (and DHEA) have been proposed to be protec-
tive against age-associated cognitive decline (Flood and Roberts,
1988; Vallee et al., 2001), a clear understanding of whether local
metabolismbyCYP7B in the hippocampus regulates its effects on
cognitionmerits investigation. To test this, we exploited the con-
siderable interindividual differences in cognitive abilities found
in aged rats (Issa et al., 1990; Gallagher et al., 1993; Yau et al.,
1995; Vallee et al., 1997) to first determine whether hippocampal
CYP7B bioactivity is related to spatial memory impairments with
aging in rats and second whether central administration of the
PREG metabolite of CYP7B metabolism, 7-hydroxyPREG, can
improve spatial memory in cognitively impaired aged rats.
Materials andMethods
Animals. Male Lister Hooded rats (Charles River, Kent, UK) were ob-
tained at 3 months of age and maintained for up to 26 months under
conditions of controlled lighting (lights on from 7:00 A.M. to 7:00 P.M.)
and temperature (22°C), with ad libitum access to food (CRMdiet cubed;
Special Diet Services, Essex, UK) and tap water. The health status was
monitored weekly by a veterinarian; animals showing overt signs of re-
spiratory distress, infection, or tumors were excluded. All procedures
were performed in strict accordance with the United Kingdom Animals
(Scientific Procedures) Act (1986).
Morris water maze. Young (6 months old; n  12) and aged rats (24
months; n  48) (500–600 g body weight) were tested for their spatial
learning performance in the Morris water maze, as described previously
(Yau et al., 1995). Themaze consisted of a 1.8-m-diameter circular white
fiberglass pool filled to a depth of 35cm with water (25°C) made opaque
with the addition of nontoxic white latex paint and was in a room with
extramaze cues on the walls around the pool. A circular escape platform
(10 cm diameter) was submerged 1.5 cm below the water surface in one
of the quadrants of the pool, and this position remained constant
throughout testing. All rats were first habituated to the maze with a 60 s
free swim in the pool and were then given 16 trials over 4 consecutive
days to learn the location of the submerged platform (four trials per day;
120 smaximum trial duration; 30 s intertrial interval). Latencies to locate
the hidden platform and swim paths were monitored by a video camera
mounted in the ceiling and a computerized tracking system [HVS image
analyzer (Kingston, UK) and Acorn Archimedes computer]. On day 5,
the rats were given a 60 s retention test of the spatial location (probe test)
with the platform absent, and the percentage time in the pool quadrants
was recorded. Finally, the rats were given four 60 s trials (visually cued) in
which the platform was raised 1 cm above the water level and had a
cardboard flag (8 5 cm) placed securely on top to render it visible. This
tested for visual, motivational, or motor deficits that may have influ-
enced performance.
The cognitive status of the aged rats was defined on the basis of their
latencies to find the platform on days 3 and 4 of testing relative to the
mean latency of the young rats. Aged impaired (AI) rats were defined as
those animals with mean latencies that differed by2 SDs from that of
the young controls. Aged unimpaired (AU) rats were identified as those
whose performance (mean latencies over days 3 and 4)was0.5 SD from
that of young controls. Aged rats that were intermediate were not further
used in the present study. The 7-hydroxylase activity in the hippocam-
pus from a selection of the cognitively tested rats was determined. Rats
were killed in themorning by decapitation, and brainswere dissected and
stored frozen at80°C before the assay. To generate sufficient numbers
of age-impaired rats to study the effects of central administration of
pregnenolone and 7-hydroxypregnenolone on spatial memory, an-
other cohort of aged rats (n  27) and young controls (n  6) were
screened for their spatial learning performance in theMorris water maze
as above. The brains from the cognitively tested rats not used in the
enzyme bioactivity assays or steroid treatment studies were stored at
80°C for future simultaneous quantification of endogenous levels of
PREG, DHEA, and their 7-hydroxylated metabolites.
CYP7B bioactivity. Individual hippocampi from young (n  6) and
aged rats defined as cognitively impaired and unimpaired (n  6 per
group) from the water maze testing were homogenized in 3 vol of ice-
cold PBS (containing 1mMEDTA, 20%glycerol, and protease inhibitors)
and centrifuged at 4000  g for 5 min at 4°C. The supernatant was
removed, and protein concentration was determined, aliquoted, and
stored at80°C until use. Ethanol solutions of [ 14C]DHEA (53.8 mCi/
mmol, 0.02 mCi/ml) were made (1:10 dilution) and dried down in glass
tubes. Incubations were performed in a total volume of 200l constitut-
ing ofW buffer (0.1 M KPO4 and 1mM EDTA, pH 7.4) and hippocampal
extract (0.5mg protein). The tubes were vortexed and placed in a shaking
water bath at 37°C, and 25 l of 8 mM NADPH was added (to give final
concentration of 1 mM). After incubating for 30 min, the reactions were
stopped by placing the tubes on ice and extracting the steroids (2 500l
ethyl acetate). The organic phase was dried down under compressed air
at 60°C and was resuspended in 30 l of ethyl acetate. The reaction
constituents were applied to silica thin-layer chromatography (TLC)
plates (Merck Biosciences, Nottingham, UK) and developed in solvent
solution (ethyl acetate, n-hexane, and acetic acid, 16:8:1). Reaction sub-
strates and products were visualized and quantified by a phosphoimager.
Treatment and behavioral testing schedule. The performance of old rats
in spatial learning tasks can be significantly influenced by previous expo-
sure to that task, even months earlier (van Groen et al., 2002). To avoid
this, the animals were retested during intracerebroventricular neuroste-
roid treatment in a spatial working memory task using the radial arm
watermaze (RAWM)because it has been reported that age-relatedmem-
ory impairments are lost with repeated testing in thewatermaze, whereas
previous experience in the watermaze did not have any effect on learning
of the radialmaze (Dellu et al., 1997). This is a cognitivelymore demand-
ing spatial learning task, so the age-impaired rats assigned for treatment
and young controls were first trained in the RAWM for 5 d (with no
delays between trials; see below) before the start of neurosteroid treat-
ment. One week after stereotaxic implantation of brain cannulas and
osmoticminipumps, the rats were tested in the RAWM(duringweek 2 of
osmotic minipump drug delivery) and were given five trials per day with
no delays for 3 d. Then on the next 2 consecutive days, they were each
given a 30mindelay retention test between trials 1 and 2. At the endof the
osmotic minipump action 2 d later, all rats were killed in the morning
(9:00–10:00 A.M.) by decapitation, trunk blood was collected in EDTA-
coated tubes for corticosteronemeasurements, and brains were removed
and stored frozen (80°C).
Surgery and steroid treatment. Animals were anesthetized with halo-
thane and subjected to stereotaxic implantation of chronic indwelling
stainless steel cannulas (Alzet brain infusion cannula; Alza, Palo Alto,
CA) into the lateral ventricle (coordinates were as follows: anteroposte-
rior, 1.0 mm posterior to bregma; lateral, 1.5 mm; dorsoventral, 4.5 mm
ventral to dura). The cannula was secured to the skull with dental acrylic,
and the external part of the intracerebroventricular cannula was con-
nectedwith polyethylene tubing to anAlzet osmoticminipump (2weeks,
0.5 l/h; model 2002; Alza) placed subcutaneously behind the neck.
Steroids were dissolved in artificial CSF with 10% hydroxypropyl beta-
cyclodextrine (a polymer that is nontoxic and devoid of intrinsic effects,
used to dissolve hydrophobic compounds in aqueousmedia). A selection
of the aged rat cohort with significantly impaired spatial learning com-
pared with young controls (as assessed in the Morris water maze task)
were randomly allocated to treatment with PREG (100 ng/h, n  6;
Sigma, Poole, UK), 7-hydroxyPREG (100 ng/h, n 7; Steraloids, New-
port, RI), or vehicle (0.5l/h, n 8). A young control vehicle group (0.5
l/h, n 6) was also included. All rats were singly housed after surgery.
The dose of PREG chosen was based on a previous study that showed
significantly increased memory performance with 100 ng/h PREG-
sulfate (S) given intracerebroventricularly inmice (Ladurelle et al., 2000)
and acute doses used in other studies (Flood and Roberts, 1988; Flood et
al., 1992). The estimated rate of CSF production in the nervous system of
mice is20l/h, whereas in rats it was520l/h (Ladurelle et al., 2000),
so the highest effective dose was chosen because this will be effectively
diluted by the greater volume of CSF in the rat. No other study has tested
the effects of the 7-hydroxylated metabolites on memory performance
and the endogenous levels in brain are not known, so the same dose as the
parent steroid was used for comparison.
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Radial arm water maze. The RAWM consisted of the 1.8 m circular
pool with eight white polypropylene inserts (54 cm high) within the tank
that divide the pool into eight swim paths (59-cm-long arms) radiating
out of an open central area (62 cm diameter). This spatially more com-
plex task forces the rat to swim in either the central open area or one of
the arms and takes advantage of the variable spatial complexity of the
radial armmaze and the efficient learning of thewatermaze (Diamond et
al., 1999). A hidden platform (10 cm diameter) was located in one of the
arms 1.5 cm below the water surface at least 8 cm from the tank wall and
remained in the samepositionwithin 1 d butwas in a different armacross
days. Each trial beganwith the rat placed directly in the entrance of one of
the arms with no hidden platform (“start arm”) with the rat facing the
central area. Start locations were randomized. Young and aged rats were
given five trials per day (60 s maximum duration) to locate the platform.
If the rat did not find the platform in 60 s, it was guided to the platformby
the experimenter. The rat remained on the platform for 30 s before the
next trial was initiated. The latency to find the platform was recorded,
and the number of errors made per trial was noted. An error was com-
mitted when a rat entered an arm that did not contain the platform or if
a rat entered the correct arm but did not find the platform. For the
memory retention trial, a 30min delay periodwas used after the first trial.
During this time, the rat was dried in a towel and placed in its cage under
a warming lamp. The rest of the trials continued with no delay. The 30
min delay was chosen because a longer delay of 60min impairedmemory
retention in young rats in our pilot studies (data not shown).
Corticosterone levels. Plasma corticosterone levels were measured by
radioimmunoassay modified for microtiter plate scintillation proximity
assay (Amersham Biosciences, Little Chalfont, UK) with a highly specific
antiserum (Dr. C. Kenyon, University of Edinburgh, Edinburgh, UK)
and [3H]corticosterone (Amersham Biosciences).
Statistical analysis.Datawere analyzed using one- or two-wayANOVA
with the age and treatment as between-subject factors. Scheffe´’s tests
were applied for post hoc analysis. For spatial learning in theMorris water
maze, the repeated within-subject factor was the day, and, for spatial
working memory in the RAWM, the trial was the within-subject factor.
All data are expressed as group means SEM. Significance was defined
as p 0.05 or p 0.01.
Results
Water maze spatial learning impairments only in a subgroup
of aged rats
Across the 4 d of training, escape latencies decreased (F(3,189) 
59.9; p  0.001) in both young and aged rats as they showed
learning of the submerged platform location. The aged rat cohort
exhibited significantly higher mean escape latencies than the
young controls (F(1,63) 16.5; p 0.05) on each day (Fig. 1A).Of
the 48 aged rats tested, 25% were classed as cognitively AI and
25% AU (Fig. 1B). The first trial latencies on day 1 of spatial
training were not significantly different between young and aged
rats ( p 0.19; young, 70.3 11.5 s; AI, 96.7 10.3 s; AU, 92.3
10.7 s). In contrast, the mean escape latencies (block of four
trials) were significantly different between AI and AU rats ( p 
0.001) but not between AU and young controls for each of days
2–4 (Fig. 1B). The day after the last acquisition trial, each rat was
given a 60 s probe test with the submerged platform absent from
the pool. AI animals spent significantly less time in the target
quadrant of the pool compared with either AU or young rats
(F(2,38) 8.3; p 0.01), whereas AU did not significantly differ
from young controls (Fig. 1C). Swim speeds were similar in
young and aged rats ( p  0.07; young, 20.7  0.6 cm/s; AU,
18.3 0.5 cm/s; AI, 19.8 0.9 cm/s), suggesting nomotor deficit
to explain differences in latency in AI rats. Furthermore, there
was no significant difference in latencies to locate the visible plat-
form between AI (6.8  0.8 s) and AU (5.7  0.3 s) or young
(6.3  0.5 s), indicating that the impaired spatial memory per-
Figure 1. Aged rats can be classed into distinct subgroups according to their spatial learning
performance in the Morris water maze. A, Aged (24–26 months; n 48) rats showed overall
impaired spatial learning (mean escape latency across days of training) compared with young
6-month-old controls (n 17).B, AI (n 12) and AU (n 12) rats were defined according to
their mean latencies across days 3 and 4 relative to the mean latency of the young (Y) rats (see
Materials and Methods); those in between are not shown. C, During the probe test (60 s free
swim in theabsenceofplatform in thepool), AI rats showed impaired spatialmemory retention,
spending significantly less time searching in the platform quadrant (TQ) but not in the opposite
quadrant (opp) compared with young or AU rats. Data are mean values SEM. *p 0.01
compared with both unimpaired and young.
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formance of the AI animals is not a consequence of poor vision or
inability to swim during this task.
CYP7B bioactivity is selectively decreased in the
hippocampus of cognitively impaired aged rats
The 7-hydroxylase activity of CYP7B in the hippocampus was
measured by incubating hippocampal microsomes from young,
AI, and AU rats with [14C]DHEA as substrate and then identifi-
cation of the [14C]7-hydroxyDHEAmetabolite produced based
on the retention factor identical to that of the reference steroid on
TLC plates. DHEAwas chosen rather than PREGbecause this has
been found previously to be the preferred substrate in rat brain
microsomes (Akwa et al., 1992; Rose et al., 1997). CYP7B bioac-
tivity was decreased (F(2,12)  13; p  0.01) selectively in AI
compared with young (34% reduction) and AU (45% reduction)
rats, whereas AU rats showed similar CYP7B bioactivity to young
controls (Fig. 2).
Spatial memory and RAWMperformance of rats before
intracerebroventricular administration of PREG
or 7-hydroxyPREG
The individual aged rat treatment groups did not differ in their
spatial learning (escape latency across days; repeated-measures
ANOVA, F(2,18) 0.08; p 0.92) (Fig. 3A) before neurosteroid
administration. All three aged rat treatment groups showed im-
paired spatial learning compared with young controls ( p 0.05)
(Fig. 3A). Spatial workingmemory, tested in the RAWM, did not
differ between aged rat treatment groups (F(2,18)  0.46; p 
0.64). All three aged rat treatment groups show significantly im-
paired spatial working memory (within-days mean trials over 3
consecutive days) compared with young controls ( p  0.01)
(Fig. 3B).
RAWMworking memory of aged rats after
intracerebroventricular administration of PREG
or 7-hydroxyPREG
Vehicle-control aged rats showed impaired short-term working
memory (within-daysmean trials over days 8 and 9 of treatment)
compared with young vehicle controls (repeated-measures
ANOVA, F(1,12) 7.2; p 0.05) (Fig. 4A). Neither PREG (F(1,12)
0.48; p  0.5) nor 7-hydroxyPREG (F(1,13)  0.33; p  0.57)
significantly affected short-term spatial learning in the aged rats
(Fig. 4A). Trial 1 latencies (F(3,23)  0.85; p  0.48) and errors
(F(3,23)  1.1; p  0.38) did not differ between the treatment
groups. On days 10 and 11 of treatment, young vehicle controls
show retention of the platform location after a 30 min delay, as
indicated by a decrease in trial 2 latency compared with trial 1
( p 0.001, paired t test) (Fig. 4B). In contrast, aged vehicle rats
showed impaired spatial memory retention (trials 1 and 2 laten-
cies did not differ; p 0.64, paired t test) (Fig. 4B). Aged vehicle
controls were impaired in both escape latencies (F(1,12)  16.5;
p  0.01) and errors (F(1,12)  28.4; p  0.001) compared with
young vehicle controls. 7-hydroxyPREG improved spatial
memory retention in the AI rats compared with aged vehicle
controls in both escape latencies (F(1,13)  7.6; p  0.05) and
errors (F(1,13)  8.2; p  0.05), and this was not significantly
different from young vehicle controls (Fig. 4B). In contrast,
PREG had no significant effect on spatial memory retention in
AI rats compared with aged vehicle controls in both escape laten-
cies (F(1,12)  2.6; p  0.13) and errors (F(1,12)  4.1; p  0.07)
(Fig. 4B).
Swim speeds and plasma corticosterone levels
The average swim speeds was not influenced by treatment (F(3,23)
1.6; p 0.2), but all groups did show significantly increased swim
Figure 2. Decreased CYP7B bioactivity in hippocampal tissue from cognitively impaired
aged rats. Hippocampal CYP7B bioactivity (as measured by the percentage conversion of
[ 14C]DHEA to [ 14C]7-hydroxyDHEA during a 30 min incubation) is decreased selectively in
cognitively impaired aged 24-month-old rats (AI, n 6) compared with age-matched cogni-
tively intact rats (AU, n 4) and young 6-month-controls (n 6). *p 0.05 compared with
AU and young.
Figure 3. Cognitive status of aged rats before steroid treatment. Before treatment, aged
24-month-old rats assigned to the different treatment groups (n 6–8/group) were equally
impaired in learning the across-days location (Morris water maze) and within-day location
(RAWM) of the platform compared with young 6-month-old controls (n 6). Data shown for
each within-day trials in RAWM are mean SEM values over 3 consecutive days.
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speeds across the five trials (F(4,92) 22.9;
p  0.001) (Table 1). Plasma corticoste-
rone levels measured from trunk blood
was not significantly affected by treatment
(young, 9.59  1.9 g/dl; old, vehicle,
13.3  1.8 g/dl; old, PREG, 13.4  5.6
g/dl; old, 7-hydroxyPREG, 7.6  1.6
g/dl).
Discussion
Although tissue-specific metabolism of
glucocorticoids by 11-hydroxysteroid
dehydrogenase type 1 (11-HSD1) affects
hippocampal-dependent learning and
memory in aged mice (Yau et al., 2001),
little is known about any analogous im-
portance of local metabolism of neuro-
steroids such as DHEA and PREG. The
major ex vivo metabolic route for PREG
andDHEA in brain is 7-hydroxylation by
CYP7B (Stapleton et al., 1995), a reaction
that is conserved across mammalian spe-
cies, including primates and humans
(Akwa et al., 1992; Doostzadeh and Mor-
fin, 1996;Weill-Engerer et al., 2003; Yau et
al., 2003). Here we describe, for the first
time, (1) a significant and selective de-
crease in hippocampal CYP7B bioactivity
in aged 24-month-old rats with impaired
spatial memory performance in the water
maze but not in age-matched cognitively
intact rats and (2) treatment with the
CYP7B product 7-hydroxyPREG to cog-
nitively impaired aged rats enhances spa-
tial memory retention after a 30 min delay
in the radial arm water maze, whereas
PREG, the parent steroid, had no signifi-
cant effect at the dose tested.
We found large interindividual differ-
ences in the spatial memory performances
of aged rats in theMorris watermaze, con-
sistent with previous reports (Issa et al.,
1990; Gallagher et al., 1993; Yau et al.,
1995). Hippocampal CYP7B bioactivity
was reduced selectively in aged-impaired, but not in aged unim-
paired, rats that maintained levels similar to young controls. De-
creased hippocampal CYP7B bioactivity is therefore not an inev-
itable consequence of aging. A previous study also reported
somewhat lower 7-hydroxylation of PREG and DHEA by
mouse brain microsomes with age (Doostzadeh and Morfin,
1996), albeit the oldest mice tested were only 10 months old, less
than half their lifespan, and these were compared with 2-month-
old juveniles [CYP7B expression in hippocampus shows a com-
plex ontogeny (Bean et al., 2001)]. Hippocampal PREG levels
decline with age and correlate with cognitive impairments in rats
(Vallee et al., 1997), suggesting that both the substrate for CYP7B
and the enzyme itself may decline in a subset of aged rodents with
cognitive deficits. Interestingly, CYP7B mRNA levels are mark-
edly reduced in surviving hippocampal neurons of Alzheimer’s
disease postmortem brain compared with age-matched controls
without CNS disease (Yau et al., 2003). It is unknown whether
CYP7Bbioactivity decreases in parallel with itsmRNAexpression
or whether this occurs in cognitive impairment without frank
dementia in aging humans. Nonetheless, data from rodents and
humans are consistent with an association between reduced hip-
pocampal CYP7B function and cognitive decline with aging.
Although recent studies have reported anti-glucocorticoid,
immunomodulatory, and antiapoptotic effects of 7-
hydroxylated DHEA (Loria and Padgett, 1998; Hampl et al.,
2000; Morfin and Starka, 2001; Pringle et al., 2003) and 7-
hyroxyPREG (Morfin and Courchay, 1994), the effect of the
CYP7B metabolites on memory have not been examined. Al-
though CYP7B bioactivity was assayed with [14C]DHEA as the
preferred substrate based on previous findings (Akwa et al., 1992;
Rose et al., 1997), we chose to examine the effects of PREG and its
7-hydroxylated metabolite on memory in the aged-impaired
rats because this is the more abundant neurosteroid in rodent
brain. DHEA is mostly a human steroid with very low levels de-
tected in rodent brain; one recent study detected 0.27 ng/gDHEA
in adult rat brain (Ebner et al., 2006). PREG, at least at the dose
tested, which has been shown previously to enhance memory
retention in young rodents (Ladurelle et al., 2000) and transiently
Figure 4. A, PREG and 7-hydroxyPREG treatment had no effect on short-term spatial learning in aged rats. After treatment,
aged vehicle controls were impaired in short-term learning compared with young vehicle controls in the eight-arm radial water
maze (withhiddenplatform indifferent armeachday). PREGand7-hydroxyPREGdidnot affect short-term learning (acquisition
trials 1–5with 30 s intertrial interval) in the aged rats. Data shown for each trial aremean SEM values over 2 consecutive days
(days 8 and 9 of treatment). B, 7-HydroxyPREG improves spatial memory retention in aged rats. Aged vehicle controls show
impaired spatial memory retention in the eight-arm radial water maze [increased escape latency ( p 0.05) and errors ( p
0.001) to locate platform after 30 min delay (retention trial 2)] compared with young controls. 7-HydroxyPREG but not PREG
treatment significantly improves memory (escape latency and errors) in aged rats. Data shown are mean SEM values over 2
consecutive days (days 10 and 11 of treatment). *p 0.001 compared with corresponding trial 1.
Table 1. Average swim speeds (cm/s) of young and aged rats in the radial armwater maze after
intracerebroventricular pregnenolone and 7-hydroxypregnenolone administration
Treatment Trial 1 Trial 2 Trial 3 Trial 4 Trial 5
Young (vehicle) 17 0.9 16 0.5 22 2.1 23 1.2 23 0.9
Old (vehicle) 17 1.3 16 1.1 18 1.5 21 1.1 20 1.1
Old (PREG) 15 0.9 15 1.5 16 1.2 20 2.2 19 1.6
Old (7-hydroxyPREG) 17 0.6 17 1.0 19 1.3 22 2.2 21 1.3
Data aremean SEM of the average swim speeds after 11 d of steroid treatment in the RAWMwith a 30min delay between trials 1 and 2 and no delays for
trials 3–5.
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improve memory deficits in cognitively impaired aged rats
(Vallee et al., 1997), did not significantly improve spatialmemory
retention in aged impaired rats (after a 30 min delay in RAWM),
although there was a trend for improved memory (decreased
errors and latency after delay). It may be that a higher dose is
required for effects on memory in aged animals. In contrast, 7-
hydroxyPREG at the same dose clearly enhanced spatial memory
retention after the delay, and this was not attributable to nonspe-
cific effects on swim speeds, which did not change with treat-
ment. Future studies should examine lower doses of 7-
hydroxyPREG as well as 7-hydroxyDHEA by intrahippocampal
infusion to confirm the primary site of action of the 7-
hydroxylated metabolites. Although hippocampal levels of 7-
hydroxyPREG and PREG in the treated rats remain to be deter-
mined, our data nevertheless show that 7-hydroxyPREG is an
activemetabolite, at least in enhancing spatialmemory retention.
Because the cognitively impaired aged rats show a 30–40% de-
cline in CYP7B bioactivity, some of the PREG administered will
still get converted to the 7-hydroxylated metabolite, whichmay
explain the trend for PREG to show some improvement inmem-
ory and why the effects of 7-hydroxyPREG in the RAWM was
not significantly better than PREG-treated aged rats. One key
study would be to treat Cyp7b knock-out mice (Rose et al., 2001)
with PREG or DHEA; the memory-enhancing effects reported
previously in mice (Flood et al., 1988, 1995) should be absent in
the Cyp7b knock-out mice if these steroids require activation by
7-hydroxylation.
Consistent with the 7-hydroxy steroids being active, periph-
eral injection of both 7-hydroxyPREG and 7-hydroxyDHEA
have been reported to increase immune responses in mice (Mor-
fin and Courchay, 1994). In addition, 7-hydroxyDHEA can be
further converted to 7-oxo-DHEA by 11-HSD1 (Robinzon et
al., 2003), itself widespread in the CNS (Moisan et al., 1990), and
7-oxo-DHEA reverses scopolamine-induced memory impair-
ments in youngmice (Shi et al., 2000). Indeed, if 7-hydroxylated
metabolites aremore active than the parent steroid, then thismay
in part explain why oral DHEA replacement in the elderly has not
successfully improved memory (Wolf et al., 1997; Huppert and
VanNiekerk, 2001), whereas DHEA administration is effective at
improvingmemory recollection andmood in healthy young sub-
jects (Alhaj et al., 2006), presumably because they maintain
greater hippocampal CYP7B activity. It may be that the 7-
hydroxylated metabolite rather than the parent steroid would be
more effective therapy in the elderly.
The mechanism of action of 7-hydroxyPREG on memory is
not clear. PREG can act via nongenomic mechanisms by binding
to the GABAA and NMDA receptors to enhance neuronal excit-
ability (Paul and Purdy, 1992; Sliwinski et al., 2004). Whether
7-hydroxyPREG also interacts with these membrane receptors
and with greater potency has yet to be determined. Anti-
glucocorticoid effects of 7-hydroxyDHEAhave been shown, for
example in counteracting dexamethasone-induced thymic and T
cell involution (May et al., 1990). 7-HydroxyDHEAmay also be
a substrate for 11-HSD1 in hepatocytes (Robinzon et al., 2003),
suggesting the possibility that it may interfere with 11-HSD1
regenerating active glucocorticoids from inert 11-keto forms
(Muller et al., 2004). Indeed, 11-HSD1 null mice lack local in-
tracellular glucocorticoid regeneration and are protected from
the decline in cognitive function seen in wild-type mice (Yau et
al., 2001). Whether 7-hydroxyPREG has similar effects to 7-
hydroxyDHEA in its neuroprotective (Pringle et al., 2003) and
anti-glucocorticoid (May et al., 1990) actions merits additional
investigation. If 7-hydroxyPREG had anti-glucocorticoid ef-
fects, this could be partly responsible for the enhanced memory
retention in the aged impaired rats because elevated glucocorti-
coid levels correlates with impaired learning in the water maze
(Issa et al., 1990; Yau et al., 1995). Although plasma corticoste-
rone levels were not significantly altered by 7-hydroxyPREG or
PREG treatment, this does not rule out changes in hippocampal
tissue corticosterone levels, which can be very different from cir-
culating levels because of the presence 11-HSD1 (Yau et al.,
2001). Future work to measure the hippocampal levels of corti-
costerone and 7-hydroxyPREG as well as other neurosteroids in
the cognitively tested aged rats (and young controls) may help
elucidate the molecular basis for the enhanced memory in the
age-impaired rat after 7-hydroxyPREG treatment. The identifi-
cation and simultaneous quantification of PREG and DHEA and
their 7-hydroxylatedmetabolites in individual rat hippocampal
samples (to allow levels to be correlated with spatial memory) is
technically very challenging. Using the LC-MS-MS (a triple
quadrupole mass spectrometer with associated HPLC) and after
converting the steroids to oxime derivatives to improve the limit
of detection, we were able to identify and quantify PREG (3
ng/g tissue) and DHEA (1 ng/g tissue) concentrations but not
7-hydroxyPREG within the same individual control whole rat
brain (N. Homer, J. Yau, J. Seckl, and R. Andrew, unpublished
preliminary data). A more sensitive method to detect the 7-
hydroxyPREG levels will require the development of a radioim-
munoassay. Intracerebroventricular administration of PREG-S
to rats has been reported previously to enhance acetylcholine
release in basolateral amygdala, cortex, and hippocampus (Mayo
et al., 2003). If this is attributable in part to the conversion to the
7-hydroxylated metabolite rather than PREG per se, then this
could be one possible explanation to the memory-enhancing ef-
fects of 7-hydroxyPREG in aged impaired rats. Whatever the
mechanism, we have shown that 7-hydroxyPREG is an active
metabolite that can enhance memory retention in aged impaired
rats thatmay have reducedCYP7B activity. Direct administration
of the 7-hydroxylated steroid product of CYP7Bmay be a novel
therapeutic approach to improve cognitive functionwith aging in
humans.
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